Gallbladder DiseaseNCT05745077
Using Data to Achieve Surgical Health Equity in the Community
A study testing Telemedicine Consultation and Traditional Care in people with Gallbladder Disease, run by University of Pennsylvania at 1 site in United States.
Trial summary
The goal of this retrospective cohort and pragmatic pilot trial is to examine the social determinants of health in racial and ethnic minority patients from socially vulnerable backgrounds who have Gallbladder Disease (GBD). The main questions it aims to answer are: 1. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Gallbladder Disease
- What is being tested?
- Telemedicine Consultation and Traditional Care
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- 16 Feb 2023to 21 May 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients age > 18 in the Primary Care Service Line (PCSL) and Emergency Department (ED) discharges including referral to surgery
- Member of a racial or ethnic minority, not primary English speaking, from a low-income neighborhood, or underinsured
- With a new ICD-10 code for symptomatic cholelithiasis or biliary colic seen by a PCSL provider or discharge from an ED between February 1, and June 30, 2023
Who cannot join
- History of prior cholecystectomy
- Prisoner
- GB cancer
- Advanced cirrhosis
- Untreated coagulopathy
- No indication for surgery
- Unable/unwilling to provide consent
Trial locations and contacts
1 site in 1 country.
United States1 site
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
About this study
The goal of this retrospective cohort and pragmatic pilot trial is to examine the social determinants of health in racial and ethnic minority patients from socially vulnerable backgrounds who have Gallbladder Disease (GBD). The main questions it aims to answer are:
- What racial barriers in outcome exist for socially vulnerable patients with gallbladder disease?
- How effective is telemedicine consultation in improving surgical outcomes for socially vulnerable patients with gallbladder disease?
Read more
Study participants will be asked to undergo telemedicine consultation in place of regular consultation with their doctor before undergoing treatment.
Researchers will compare the telemedicine consultation groups with traditional care patients to see if telemedicine consultation is effective at reducing surgical disparity outcomes.
Read the detailed description
This study seeks to identify differences in the care paradigms to find and test solutions to racial disparities in emergent cholecystectomy, as well as develop and test a pilot study to compare the effectiveness of telemedicine consultation. To address surgical health equity in patients with gallbladder disease, this study aims to:
- Examine racial disparities in outcomes of Primary Care Service Line (PCSL) patients with symptomatic GB disease with attention to conditional effects of social vulnerabilities (SV)
- Compare the effectiveness study of telemedicine consultation for symptomatic GB disease in patients with social vulnerabilities
This study will be divided into two phases to address each aim. The first aim will be conducted as a retrospective cohort study and examine the outcomes of PCSL patients diagnosed with symptomatic GB disease between Jan. 1, 2020 and Sept. 30, 2022 using PennMedicine data to build regression models with interaction terms to examine racial disparities in surgical consultation and the conditional effects of SV factors on this relationship. The second aim will be performed as a pragmatic pilot trial of Penn PCSL patients with SV. For this aim, the investigators will pragmatically assign two groups to traditional care and telemedicine consultation and study the resultant outcomes from patients with diagnosed with symptomatic cholelithiasis or biliary colic as seen by a PCSL provider between April 1, and June 30, 2023. These results will provide data to develop evidence-based solutions to racial disparities within Penn Medicine and to serve as preliminary data for subsequent studies to promote health equity in patients with symptomatic GBD.
- Conditions
- Gallbladder Disease
- Being tested
- Telemedicine Consultation, Traditional Care
- Keywords
- Social Determinants of Health, Telemedicine, Elective Cholecystectomy, Emergency Cholecystectomy
- Medical subject headings
- Gallbladder Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Telemedicine ConsultationBehavioural
Patients will be contacted by their surgeon over the phone to discuss surgical treatment.
Traditional CareBehavioural
Patients will proceed with their surgical consultation as per standard practice.
| Study group | Role | What they receive |
|---|---|---|
| Telemedicine Consultation | Experimental | Patient will schedule a Telemedicine Consultation in place of traditional in-person visit. Receives: Behavioral: Telemedicine Consultation |
| Traditional In-Person Care | Active comparator | Patient will schedule a traditional in-person visit as per usual care. Receives: Behavioral: Traditional Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cholecystectomy Surgical Outcome
Compare rates of surgical consultation by consultation type.
Measured: 6 Months
Secondary outcomes (5)
Time from Referral to Consultation
Number of days between initial documentation of referral to surgery by provider and initial pre-operative consultation with surgeon by consultation type. Identified by EMR documentation and encounter visits.
Measured: 6 Months
Completion of Consultation
Completion of initial pre-operative consultation visit with surgeon for patients referred to surgery. Identified by EMR documentation and encounter visits.
Measured: 6 Months
Effect of Consultation on Surgical Outcome.
Operative treatment outcomes received by patients who received pre-operative consultation with the surgeon. Operative treatment will be determined using CPT and ICD-10-PCS codes for cholecystectomy as listed in HPM (CPT 47562, CPT 47563, CPT 47600, CPT 47605, CPT 56340, CPT 56341, ICD10 0FB40ZX, ICD10 OFB40ZZ, ICD10 OFT40ZZ).
Measured: 6 Months
Urgency of Operative Treatment
Urgency for operative treatment for whether cholecystectomy was performed in the emergent or elective setting as determined by admission source for the associated operative encounter and CPT and ICD-10-PCS codes for cholecystectomy as listed in HPM (CPT 47562, CPT 47563, CPT 47600, CPT 47605, CPT 56340, CPT 56341, ICD10 0FB40ZX, ICD10 OFB40ZZ, ICD10 OFT40ZZ).
Measured: 6 Months
Cost
Cost of care including preoperative consultation visit with the surgeon and cholecystectomy visit. Data will be obtained from Horizon Performance Manager.
Measured: 6 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Feb 2023
- Study start16 Feb 2023
- Primary completion4 Mar 2024
- Study completion21 May 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (33)Papers the sponsor has linked to this study.
- Other trials for Gallbladder DiseaseStudies of the same condition, open and under way.
- More trials run by University of PennsylvaniaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Pennsylvania
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Rachel Kelz, MD, Principal investigator, University of Pennsylvania
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05745077
- Sponsor's protocol ID
- 852524
- Status last verified
- Jun 2024
- First submitted
- 31 Jan 2023
- Last updated
- 6 Jun 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Cox, M.R., G.D. Eslick, and R. Padbury, The management of gallstone disease: a practical and evidence-based approach. 2018: Springer.
Altieri MS, Yang J, Zhu C, Sbayi S, Spaniolas K, Talamini M, Pryor A. What happens to biliary colic patients in New York State? 10-year follow-up from emergency department visits. Surg Endosc. 2018 Apr;32(4):2058-2066. doi: 10.1007/s00464-017-5902-5. Epub 2017 Oct 23.
PubMed 29063306Prevention, C.f.D.C.a. Adult Obesity Facts. Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion 2022 May 17, 2022 [cited 2022 September 19, 2022]; Available from: https://www.cdc.gov/obesity/data/adult.html#:~:text=Obesity%20affects%20some%20groups%20more%20than%20others&text=Non%2DHispanic%20Black%20adults%20(49.9,Hispanic%20Asian%20adults%20(16.1%25).%20Accessed%2009/18/2022.
Overby DW, Apelgren KN, Richardson W, Fanelli R; Society of American Gastrointestinal and Endoscopic Surgeons. SAGES guidelines for the clinical application of laparoscopic biliary tract surgery. Surg Endosc. 2010 Oct;24(10):2368-86. doi: 10.1007/s00464-010-1268-7. Epub 2010 Aug 13. No abstract available.
PubMed 20706739Radunovic M, Lazovic R, Popovic N, Magdelinic M, Bulajic M, Radunovic L, Vukovic M, Radunovic M. Complications of Laparoscopic Cholecystectomy: Our Experience from a Retrospective Analysis. Open Access Maced J Med Sci. 2016 Dec 15;4(4):641-646. doi: 10.3889/oamjms.2016.128. Epub 2016 Nov 9.
PubMed 28028405Cheruvu CV, Eyre-Brook IA. Consequences of prolonged wait before gallbladder surgery. Ann R Coll Surg Engl. 2002 Jan;84(1):20-2.
PubMed 11892728Sobolev B, Mercer D, Brown P, FitzGerald M, Jalink D, Shaw R. Risk of emergency admission while awaiting elective cholecystectomy. CMAJ. 2003 Sep 30;169(7):662-5.
PubMed 14517123To KB, Cherry-Bukowiec JR, Englesbe MJ, Terjimanian MN, Shijie C, Campbell DA Jr, Napolitano LM. Emergent versus elective cholecystectomy: conversion rates and outcomes. Surg Infect (Larchmt). 2013 Dec;14(6):512-9. doi: 10.1089/sur.2012.160. Epub 2013 Nov 25.
PubMed 24274058Rutledge D, Jones D, Rege R. Consequences of delay in surgical treatment of biliary disease. Am J Surg. 2000 Dec;180(6):466-9. doi: 10.1016/s0002-9610(00)00520-1.
PubMed 11182399Munoz E, Tinker MA, Margolis I, Wise L. Surgonomics: the cost of cholecystectomy. Surgery. 1984 Oct;96(4):642-7.
PubMed 6435271Carmichael H, Moore A, Steward L, Velopulos CG. Using the Social Vulnerability Index to Examine Local Disparities in Emergent and Elective Cholecystectomy. J Surg Res. 2019 Nov;243:160-164. doi: 10.1016/j.jss.2019.05.022. Epub 2019 Jun 6.
PubMed 31177035Lin JA, Braun HJ, Schwab ME, Pierce L, Sosa JA, Wick EC. Pandemic Recovery: Persistent Disparities in Access to Elective Surgical Procedures. Ann Surg. 2023 Jan 1;277(1):57-65. doi: 10.1097/SLA.0000000000004848. Epub 2021 Mar 3.
PubMed 33914483Shenoy R, Kirkland P, Maggard-Gibbons M, Russell MM. Symptomatic Cholelithiasis: Do Minority Patients Experience Delays to Surgery? J Surg Res. 2022 Apr;272:88-95. doi: 10.1016/j.jss.2021.11.003. Epub 2021 Dec 22.
PubMed 34953371Janeway MG, Sanchez SE, Rosen AK, Patts G, Allee LC, Lasser KE, Dechert TA. Disparities in Utilization of Ambulatory Cholecystectomy: Results From Three States. J Surg Res. 2021 Oct;266:373-382. doi: 10.1016/j.jss.2021.03.052. Epub 2021 Jun 1.
PubMed 34087621Saluja S, Hochman M, Dokko R, Morrison JL, Valdez C, Baldwin S, Tandel MD, Cousineau M. Community-Based Health Care Navigation's Impact on Access to Primary Care for Low-Income Latinos. J Am Board Fam Med. 2022 Jan-Feb;35(1):44-54. doi: 10.3122/jabfm.2022.01.210253.
PubMed 35039411
Study at a glance
From the registry record, last updated by the sponsor on 6 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Using Data to Achieve Surgical Health Equity in the Community
- ClinicalTrials.gov ID
- NCT05745077
- Acronym / sponsor ID
- 852524
- Conditions
- Gallbladder Disease
- Keywords
- Social Determinants of Health, Telemedicine, Elective Cholecystectomy, Emergency Cholecystectomy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- University of PennsylvaniaUniversity, hospital or other
- Study start
- 16 Feb 2023 (actual)
- Primary completion
- 4 Mar 2024 (actual)
- Study completion
- 21 May 2024 (actual)
- First posted
- 27 Feb 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this retrospective cohort and pragmatic pilot trial is to examine the social determinants of health in racial and ethnic minority patients from socially vulnerable backgrounds who have Gallbladder Disease (GBD). The main questions it aims to answer are:
- What racial barriers in outcome exist for socially vulnerable patients with gallbladder disease?
- How effective is telemedicine consultation in improving surgical outcomes for socially vulnerable patients with gallbladder disease?
Study participants will be asked to undergo telemedicine consultation in place of regular consultation with their doctor before undergoing treatment.
Researchers will compare the telemedicine consultation groups with traditional care patients to see if telemedicine consultation is effective at reducing surgical disparity outcomes.
Detailed description
This study seeks to identify differences in the care paradigms to find and test solutions to racial disparities in emergent cholecystectomy, as well as develop and test a pilot study to compare the effectiveness of telemedicine consultation. To address surgical health equity in patients with gallbladder disease, this study aims to:
- Examine racial disparities in outcomes of Primary Care Service Line (PCSL) patients with symptomatic GB disease with attention to conditional effects of social vulnerabilities (SV)
- Compare the effectiveness study of telemedicine consultation for symptomatic GB disease in patients with social vulnerabilities
This study will be divided into two phases to address each aim. The first aim will be conducted as a retrospective cohort study and examine the outcomes of PCSL patients diagnosed with symptomatic GB disease between Jan. 1, 2020 and Sept. 30, 2022 using PennMedicine data to build regression models with interaction terms to examine racial disparities in surgical consultation and the conditional effects of SV factors on this relationship. The second aim will be performed as a pragmatic pilot trial of Penn PCSL patients with SV. For this aim, the investigators will pragmatically assign two groups to traditional care and telemedicine consultation and study the resultant outcomes from patients with diagnosed with symptomatic cholelithiasis or biliary colic as seen by a PCSL provider between April 1, and June 30, 2023. These results will provide data to develop evidence-based solutions to racial disparities within Penn Medicine and to serve as preliminary data for subsequent studies to promote health equity in patients with symptomatic GBD.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Telemedicine Consultation | Experimental | Behavioral: Telemedicine ConsultationPatient will schedule a Telemedicine Consultation in place of traditional in-person visit. |
| Traditional In-Person Care | Active comparator | Behavioral: Traditional CarePatient will schedule a traditional in-person visit as per usual care. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patients age > 18 in the Primary Care Service Line (PCSL) and Emergency Department (ED) discharges including referral to surgery
- Member of a racial or ethnic minority, not primary English speaking, from a low-income neighborhood, or underinsured
- With a new ICD-10 code for symptomatic cholelithiasis or biliary colic seen by a PCSL provider or discharge from an ED between February 1, and June 30, 2023
Key exclusion criteria (7 listed)
- History of prior cholecystectomy
- Prisoner
- GB cancer
- Advanced cirrhosis
- Untreated coagulopathy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Telemedicine ConsultationPatients will be contacted by their surgeon over the phone to discuss surgical treatment. | Behavioural | Telemedicine Consultation |
| Traditional CarePatients will proceed with their surgical consultation as per standard practice. | Behavioural | Traditional In-Person Care |
Primary outcome
Cholecystectomy Surgical Outcome
Time frame: 6 Months
Compare rates of surgical consultation by consultation type.
5 secondary outcomes
Time from Referral to Consultation
Time frame: 6 Months
Completion of Consultation
Time frame: 6 Months
Effect of Consultation on Surgical Outcome.
Time frame: 6 Months
Urgency of Operative Treatment
Time frame: 6 Months
Cost
Time frame: 6 Months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jun 2024.
- BackgroundCox, M.R., G.D. Eslick, and R. Padbury, The management of gallstone disease: a practical and evidence-based approach. 2018: Springer.
- Background: PubMed 29063306Altieri MS, Yang J, Zhu C, Sbayi S, Spaniolas K, Talamini M, Pryor A. What happens to biliary colic patients in New York State? 10-year follow-up from emergency department visits. Surg Endosc. 2018 Apr;32(4):2058-2066. doi: 10.1007/s00464-017-5902-5. Epub 2017 Oct 23.
- BackgroundPrevention, C.f.D.C.a. Adult Obesity Facts. Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion 2022 May 17, 2022 [cited 2022 September 19, 2022]; Available from: https://www.cdc.gov/obesity/data/adult.html#:~:text=Obesity%20affects%20some%20groups%20more%20than%20others&text=Non%2DHispanic%20Black%20adults%20(49.9,Hispanic%20Asian%20adults%20(16.1%25).%20Accessed%2009/18/2022.
- Background: PubMed 20706739Overby DW, Apelgren KN, Richardson W, Fanelli R; Society of American Gastrointestinal and Endoscopic Surgeons. SAGES guidelines for the clinical application of laparoscopic biliary tract surgery. Surg Endosc. 2010 Oct;24(10):2368-86. doi: 10.1007/s00464-010-1268-7. Epub 2010 Aug 13. No abstract available.
- Background: PubMed 28028405Radunovic M, Lazovic R, Popovic N, Magdelinic M, Bulajic M, Radunovic L, Vukovic M, Radunovic M. Complications of Laparoscopic Cholecystectomy: Our Experience from a Retrospective Analysis. Open Access Maced J Med Sci. 2016 Dec 15;4(4):641-646. doi: 10.3889/oamjms.2016.128. Epub 2016 Nov 9.
- Background: PubMed 11892728Cheruvu CV, Eyre-Brook IA. Consequences of prolonged wait before gallbladder surgery. Ann R Coll Surg Engl. 2002 Jan;84(1):20-2.
- Background: PubMed 14517123Sobolev B, Mercer D, Brown P, FitzGerald M, Jalink D, Shaw R. Risk of emergency admission while awaiting elective cholecystectomy. CMAJ. 2003 Sep 30;169(7):662-5.
- Background: PubMed 24274058To KB, Cherry-Bukowiec JR, Englesbe MJ, Terjimanian MN, Shijie C, Campbell DA Jr, Napolitano LM. Emergent versus elective cholecystectomy: conversion rates and outcomes. Surg Infect (Larchmt). 2013 Dec;14(6):512-9. doi: 10.1089/sur.2012.160. Epub 2013 Nov 25.
- Background: PubMed 11182399Rutledge D, Jones D, Rege R. Consequences of delay in surgical treatment of biliary disease. Am J Surg. 2000 Dec;180(6):466-9. doi: 10.1016/s0002-9610(00)00520-1.
- Background: PubMed 6435271Munoz E, Tinker MA, Margolis I, Wise L. Surgonomics: the cost of cholecystectomy. Surgery. 1984 Oct;96(4):642-7.
- Background: PubMed 31177035Carmichael H, Moore A, Steward L, Velopulos CG. Using the Social Vulnerability Index to Examine Local Disparities in Emergent and Elective Cholecystectomy. J Surg Res. 2019 Nov;243:160-164. doi: 10.1016/j.jss.2019.05.022. Epub 2019 Jun 6.
- Background: PubMed 33914483Lin JA, Braun HJ, Schwab ME, Pierce L, Sosa JA, Wick EC. Pandemic Recovery: Persistent Disparities in Access to Elective Surgical Procedures. Ann Surg. 2023 Jan 1;277(1):57-65. doi: 10.1097/SLA.0000000000004848. Epub 2021 Mar 3.
- Individual participant dataSharing planned: No
Related trials for Gallbladder Disease
Active, not recruitingPhase 2/3
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
Biliary Tract Cancer, Cholangiocarcinoma
Not yet recruitingPhase 4
Effect of Prophylactic Dexamethasone vs Placebo on Airway Dimensions Assessed by Ultrasonography in Patients Undergoing Laparoscopic Cholecystectomy
Airway Edema, Postoperative Complications
Not yet recruitingPhase 3
Hepatic Arterial Infusion Chemotherapy Versus Capecitabine as Adjuvant Therapy for Resected Biliary Tract Cancer
Biliary Tract Cancer, Cholangiocarcinoma
Recruiting
Distance-Based Exercise to Preserve Function and Prevent Disability
Localized Malignant Solid Neoplasm, Anal Cancer
RecruitingPhase 2
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Solid Tumors, HER2 Mutation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rachel Kelz, MD principal investigator
University of Pennsylvania
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Telemedicine Consultation and Traditional Care in people with Gallbladder Disease, run by University of Pennsylvania at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cholecystectomy Surgical Outcome (time frame: 6 Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05745077, which also lists 33 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2024.